BioSpace News Archive

Tubulis and Glycotope announced that they have signed a research and feasibility agreement, providing Glycotope access to Tubulis’ proprietary antibody drug conjugate technologies.

Sensorion has contributed three presentations at the 56th Workshop on Inner Ear Biology (IEB 2019) held in Padua, the 7-10th of September, 2019.

BIA Separations announced the introduction of CORNERSTONE AAV Process Development Service, a program of integrated process development services and novel technology designed to improve the robustness and yield of AAV-based gene therapy production, while improving the safety of therapeutic products.

Merck KGaA, Darmstadt, Germany, announced that the US Food and Drug Administration has granted Breakthrough Therapy Designation for the investigational targeted therapy tepotinib* in patients with metastatic non-small cell lung cancer harboring MET exon 14 skipping alterations who progressed following platinum-based cancer therapy.

Program creates incubator for developing cutting-edge workflow innovations leveraging Epic EMR

World-renowned transformational leaders Preethaji and Krishnaji will live stream daily from India, 60-minute meditations from September 12 to September 22

Goal is to increase access to complex medications to ensure patients get the right drug at the right time faster

Dr. Reddy’s Laboratories Ltd. announced the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND® (fosaprepitant) for injection, approved by the U.S. Food and Drug Administration (USFDA).

Immunexpress, Inc. today announced that Jane Papadaki Markley has joined the company’s Executive Team as Vice President of Market Development and Commercial Operations.

China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma,” “CPHI”, the “Company” or “We”), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it has entered into a Memorandum of Understanding (MOU) and the Addendum with World Health Advanced Technologies, Ltd (W.H.A.T.)